| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |